Clinical trial
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar…
NCT00258687 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00258687 |
|---|---|
| Title | Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma |
| Official title | A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Tumor Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Pediatric and Adult Patients |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Boston Children's Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma, Clear Cell, Alveolar Soft Part, Renal Cell Carcinoma, Melanoma |
| Intervention type | Biological |
| Interventions | GVAX |
| Enrollment | 12 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Dec 1, 2020 |
| First posted | Nov 28, 2005 |
| Last update posted | Mar 3, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: